Landos Biopharma, Inc. Quarterly Operating Lease, Payments in USD from Q1 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Landos Biopharma, Inc. quarterly Operating Lease, Payments history and growth rate from Q1 2022 to Q3 2023.
  • Landos Biopharma, Inc. Operating Lease, Payments for the quarter ending September 30, 2023 was $200K.
Operating Lease, Payments, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $200K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2022 $200K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $200K Jan 1, 2022 Mar 31, 2022 10-K 2024-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.